Viatris Inc., a global healthcare company, announced that Scott A. Smith and Elisha W. Finney have been appointed as Viatris’ newest members of its board of directors. Smith and Finney fill the vacancies created by the retirement of Neil Dimick and Ian Reid. Scott Smith is a deeply experienced global biotechnology and pharmaceutical executive who currently serves as President and Executive Director of…
Biocon Biologics Ltd., a subsidiary of Biocon Ltd., announced that it has successfully completed its multi-billion-dollar (USD) acquisition of the global biosimilars business of its partner Viatris Inc. Biocon Biologics and Viatris have obtained all applicable approvals from key global regulators including the U.S. Federal Trade Commission, the Competition Commission of India and the Reserve…
Mylan, a global pharmaceutical company, announced an agreement to acquire the related intellectual property and commercialization rights of Aspen Pharmacare Holdings Limited’s thrombosis business in Europe for EUR 641.9 million, subject to customary closing conditions and European regulatory clearances. The transaction is expected to be immediately accretive to Mylan upon closing and is anticipated to…